| 000 | 01321 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250514225340.0 | ||
| 264 | 0 | _c20050802 | |
| 008 | 200508s 0 0 rus d | ||
| 022 | _a0040-3660 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMychka, V B | |
| 245 | 0 | 0 |
_a[Body mass loss due to orlistat therapy and multiple factors of cardiovascular risk]. _h[electronic resource] |
| 260 |
_bTerapevticheskii arkhiv _c2005 |
||
| 300 |
_a55-60 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Obesity Agents _xadverse effects |
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xetiology |
| 650 | 0 | 4 | _aCerebral Angiography |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin _xblood |
| 650 | 0 | 4 | _aInsulin Resistance |
| 650 | 0 | 4 |
_aLactones _xadverse effects |
| 650 | 0 | 4 | _aLipid Metabolism |
| 650 | 0 | 4 |
_aLipids _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetabolic Syndrome _xcomplications |
| 650 | 0 | 4 | _aOrlistat |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aWeight Loss |
| 700 | 1 | _aGornostaev, V V | |
| 700 | 1 | _aAtaullakhanova, D M | |
| 700 | 1 | _aDvoskina, I M | |
| 700 | 1 | _aSergienko, V B | |
| 700 | 1 | _aChazova, I E | |
| 773 | 0 |
_tTerapevticheskii arkhiv _gvol. 77 _gno. 3 _gp. 55-60 |
|
| 999 |
_c15544266 _d15544266 |
||